The global mammography market was valued at USD 2,725.89 million in 2024 and is projected to reach USD 2,953.50 million in 2025 and USD 6,205.87 million by 2034, growing at a CAGR of 8.6% during the forecast period 2025–2034. North America was the largest regional market in 2024. The mammography market encompasses medical imaging technologies used for breast cancer screening and diagnosis, including digital mammography, 3D tomosynthesis and analog systems. Key players include Canon Medical Systems Corporation, Carestream Health, Inc., Delphinus Medical Technologies, Inc., Dilon Technologies, Inc., Fujifilm Holdings Corporation, GE HealthCare, Hologic, Inc., IMS Giotto S.p.A., KUB Technologies, Inc., Koninklijke Philips N.V., Metaltronica S.p.A., Micrima Limited, Planmed Oy, Siemens Healthineers, and SuperSonic Imagine.

Digital Mammography Replaces Analog Systems

Innovation in imaging technology has enhanced the effectiveness of the mammography market. The transition from analog to digital systems has improved image clarity and diagnostic accuracy, and the shift toward digital mammography offers better image quality, faster results and improved patient outcomes. Among suppliers, Siemens Healthineers offers a comprehensive portfolio of digital mammography solutions focused on patient comfort and diagnostic precision, while Fujifilm Holdings Corporation has developed digital mammography systems emphasizing image quality and dose efficiency.

Digital Breast Tomosynthesis and 3D Mammography

The mammography market by modality is segmented into multimodal and standalone. The standalone modality, which uses a single imaging technique such as digital mammography or digital breast tomosynthesis, held the larger share in 2024 owing to its established efficacy, accessibility and widespread adoption in routine screening. The adoption of 3D mammography, or breast tomosynthesis, has improved image clarity and diagnostic accuracy and supports earlier detection of breast cancer. Hologic, Inc. is renowned for its 3D mammography systems, and GE HealthCare provides digital mammography and breast tomosynthesis systems.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/mammography-market

Recent launches reflect this focus. In November 2024, GE HealthCare launched the Pristina Via system, which offers vendor-neutral prior image comparison and reduced radiation doses across all breast thicknesses. In September 2024, Siemens Healthineers AG received US FDA premarket approval for the 3D imaging technology of its Mammomat B.brilliant system, designed to improve patient comfort and user ergonomics.

Artificial Intelligence Integration Improves Diagnostics

Artificial intelligence integration is improving diagnostic accuracy and efficiency in breast imaging. AI-based solutions are being integrated to speed up image interpretation and reduce human error. In May 2025, Sir H. N. Reliance Foundation Hospital introduced South Asia's first Genius AI 3D mammography system, which delivers scans in just 3.7 seconds and increases the detection of invasive cancers by up to 65%. Artificial intelligence integration and 3D imaging are two of the key trends identified in the report.

Multimodal Approaches and Dense Breast Tissues

The multimodal segment, which combines modalities such as mammography and ultrasound, is experiencing a higher growth rate. This reflects growing recognition of the limitations of standalone systems, especially in detecting cancers in dense breast tissues. Multimodal approaches provide complementary information that improves sensitivity and specificity, and studies have shown that integrating mammography with ultrasound significantly improves diagnostic performance, particularly in differentiating benign from malignant lesions.

Application and End-Use Segmentation

By application, the market is segmented into diagnostic screening, advance imaging and clinical review. Diagnostic screening dominated owing to widespread government-funded breast screening programs, while advance imaging is experiencing substantial growth as advanced technologies provide clearer visualization of breast tissue. By end use, hospitals held the largest share in 2024 because of the high volume of screenings conducted there and continuous technological advancements in mammography workstations.

Competitive Insight for the Mammography Market

mammography  players are actively engaged in research and development to enhance imaging technologies, improve diagnostic accuracy and increase patient comfort. Koninklijke Philips N.V. delivers solutions designed to improve workflow and patient experience, Canon Medical Systems Corporation offers a range of imaging solutions, and Metaltronica S.p.A. provides analog and digital systems focused on reliability and performance.

More Trending Latest Reports By Polaris Market Research:

Cloud Based Contact Center Market

Robotic Palletizer Market

Robotic Platform Market

Lignans Market

Cell Isolation/Cell Separation Market

Anti-Counterfeit Packaging Market

Border Security Market

Oral Solid Dosage Contract Manufacturing Market

Maritime Patrol Aircraft Market

Digital Pharmacy Market